CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $214,000 | -27.5% | 30,538 | -14.1% | 0.03% | -12.9% |
| Q1 2022 | $295,000 | -2.3% | 35,538 | -20.2% | 0.03% | +3.3% |
| Q4 2021 | $302,000 | -4.4% | 44,538 | -25.2% | 0.03% | -9.1% |
| Q3 2021 | $316,000 | -7.6% | 59,538 | 0.0% | 0.03% | -8.3% |
| Q2 2021 | $342,000 | +24.8% | 59,538 | 0.0% | 0.04% | +16.1% |
| Q1 2021 | $274,000 | +37.7% | 59,538 | 0.0% | 0.03% | +24.0% |
| Q4 2020 | $199,000 | +61.8% | 59,538 | +43.3% | 0.02% | +47.1% |
| Q3 2020 | $123,000 | – | 41,538 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |